Literature DB >> 181490

Cellular immunity in chronic Theiler's virus central nervous system infection.

S G Rabinowitz, H L Lipton.   

Abstract

After (IC) inoculation of the DA strain of TMEV, SJL/J mice develop chronic CNS infection with marked mononuclear cell infiltration of spinal cord leptomeninges and white matter and concomitant demyelination. In the present study the temporal course of cell-mediated and humoral immune responses to virus were measured in this infection. It was shown that chronic TMEV infection is associated with the development of immunologically specific spleen cell reactivity as judged by in vitro incorporation of 3H-TdR into DNA in response to inactivated TMEV antigen. Spleen cell reactivity is first detectable about 2 months after infection, persists for at least 1 year, and correlates with the temporal development of serum-neutralizing antibody. The late development of sensitized spleen cells is not the result of an immunosuppressive effect of this virus infection since infected mice exhibit normal spleen cell proliferative responses to T cell mitogens and produce normal antibody responses to a heterologous protein antigen, sheep red blood cells. In addition, anti-viral antibody inhibits virus-induced spleen cell reactivity. Finally, the antigen-reactive lymphocyte subpopulation within the spleen responsible for proliferation to TMEV antigen are T cells and not B cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181490

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Meningeal exudate cells in vaccinia meningitis of mice: role of local T cells.

Authors:  T Morishima; K Hayashi
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

2.  Antigenic variants are not selected during persistent infection with Theiler's virus.

Authors:  J L Leibowitz; M Rodriguez
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

3.  Relationship between host age and persistence of Theiler's virus in the central nervous system of mice.

Authors:  C M Steiner; E J Rozhon; H L Lipton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

4.  Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.

Authors:  R S Fujinami; A Rosenthal; P W Lampert; A Zurbriggen; M Yamada
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  Lymphocyte recognition elements on the VP1 protein of Theiler's virus.

Authors:  E J Usherwood; I C Johnston; L J Lovelidge; P Tonks; A A Nash
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

6.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus.

Authors:  H L Lipton; M C Dal Canto
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

8.  Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus.

Authors:  P Sethi; H L Lipton
Journal:  Br J Exp Pathol       Date:  1983-02

9.  Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.

Authors:  P Borrow; C J Welsh; A A Nash
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

Review 10.  Immunology of Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; J Kuzmak; R A Good; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.